SPECTRUM OF BRCA1, BRCA2, PALB2, ATM AND TP53 PATHOGENIC VARIANTS IN BREAST AND OVARIAN CANCER PATIENTS OF TATAR AND BASHKIR ETHNIC ORIGIN

被引：0
|
作者：
Imyanitov, Evgeny [1 ]
Bakayeva, Elvina [1 ]
Sultanbayev, Alexandr [2 ]
Faiskhanova, Raniya [2 ]
Mukhamediarova, Gulnara [3 ]
Fatikhova, Alfiya [2 ]
Askarov, Vadim [2 ]
Venina, Aigul [1 ]
Romanko, Alexandr [1 ]
Sokolenko, Anna [1 ]
机构：
[1] NN Petrov Inst Oncol, St Petersburg, Russia
[2] Bashkortostan Republican Canc Ctr, Ufa, Russia
[3] Tatarstan Republican Canc Ctr, Kazan, Russia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷
基金：
俄罗斯科学基金会;
关键词：
D O I：
10.1136/ijgc-2023-ESGO.779
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
432
引用
收藏
页码：A368 / A368
页数：1
相关论文
共 50 条
  • [31] Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer
    Walsh, T
    Casadei, S
    Coats, KH
    Swisher, E
    Stray, SM
    Higgins, J
    Roach, KC
    Mandell, J
    Lee, MK
    Ciernikova, S
    Foretova, L
    Soucek, P
    King, MC
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (12): : 1379 - 1388
  • [32] CLINICOPATHOLOGICAL CHARACTERISTICS AND BRCA1 /BRCA2 PATHOGENIC VARIANTS OF PATIENTS WITH BREAST CANCER
    Eras, Nazan
    Tuncel, Ferah
    Altintas, Zuhal
    Erden, Sema
    POLISH JOURNAL OF PATHOLOGY, 2024, 75 (01) : 1 - 7
  • [33] Surgery for BRCA, TP53 and PALB2: a literature review
    Song, Chin-Vern
    Teo, Soo-Hwang
    Taib, Nur Aishah
    Yip, Cheng-Har
    ECANCERMEDICALSCIENCE, 2018, 12
  • [34] Population-based Estimates of contralateral Breast Cancer Risk among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2
    Yadav, Siddhartha
    Boddicker, Nicholas J.
    Na, Jie
    Polley, Eric C.
    Hu, Chunling
    Hart, Steven N.
    Gnanaolivu, Rohan D.
    Larson, Nicole
    Dunn, Carolyn
    Holtegaard, Susan
    Huang, Huaizhi
    Teras, Lauren R.
    Patel, Alpa V.
    Lacey, James V., Jr.
    Neuhausen, Susan
    Bernstein, Leslie
    Martinez, Elena
    Haiman, Christopher
    Chen, Fei
    Ruddy, Kathryn
    Olson, Janet
    John, Esther
    Kurian, Allison W.
    Sandler, Dale P.
    O'Brien, Katie M.
    Taylor, Jack A.
    Weinberg, Clarice R.
    Anton-Culver, Hoda
    Ziogas, Argyrios
    Zirpoli, Gary R.
    Goldgar, David E.
    Nathanson, Katherine L.
    Domchek, Susan
    Palmer, Julie R.
    Weitzel, Jeffrey
    Kraft, Peter
    Couch, Fergus J.
    CANCER RESEARCH, 2023, 83 (05)
  • [35] A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago
    Donenberg, Talia
    Ahmed, Humayun
    Royer, Robert
    Zhang, Shiyu
    Narod, Steven A.
    George, Sophia
    Akbari, Mohammad R.
    Ali, Jameel
    Hurley, Judith
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 159 (01) : 131 - 138
  • [36] A Survey of BRCA1, BRCA2, and PALB2 mutations in women with breast cancer in Trinidad and Tobago
    Talia Donenberg
    Humayun Ahmed
    Robert Royer
    Shiyu Zhang
    Steven A. Narod
    Sophia George
    Mohammad R. Akbari
    Jameel Ali
    Judith Hurley
    Breast Cancer Research and Treatment, 2016, 159 : 131 - 138
  • [37] Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50years
    Petridis, Christos
    Arora, Iteeka
    Shah, Vandna
    Megalios, Anargyros
    Moss, Charlotte
    Mera, Anca
    Clifford, Angela
    Gillett, Cheryl
    Pinder, Sarah E.
    Tomlinson, Ian
    Roylance, Rebecca
    Simpson, Michael A.
    Sawyer, Elinor J.
    BREAST CANCER RESEARCH, 2019, 21 (1):
  • [38] Hereditary breast and ovarian cancer: two cases of double heterozigosity for pathogenic variants in the BRCA1 or BRCA2 and ATM genes
    Theisen, P.
    Rodrigues, P.
    Silva, C.
    Carpinteiro, D.
    Ribeiro, L.
    Carreiro, H.
    Gervasio, H.
    Leal da Silva, J.
    Vieira, L.
    Goncalves, J.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 494 - 495
  • [39] BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma
    Christian Monnerat
    Agnès Chompret
    Caroline Kannengiesser
    Marie-Françoise Avril
    Nicolas Janin
    Alain Spatz
    Jean-Marc Guinebretière
    Catalin Marian
    Michel Barrois
    Françoise Boitier
    Gilbert M. Lenoir
    Brigitte Bressac-de Paillerets
    Familial Cancer, 2007, 6 : 453 - 461
  • [40] BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma
    Monnerat, Christian
    Chompret, Agnes
    Kannengiesser, Caroline
    Avril, Marie-Francois
    Janin, Nicolas
    Spatz, Alain
    Guinebretiere, Jean-Marc
    Marian, Catalin
    Barrois, Michel
    Boitier, Francois
    Lenoir, Gilbert M.
    Paillerets, Brigitte Bressac-de
    FAMILIAL CANCER, 2007, 6 (04) : 453 - 461
12345